BRIEF published on 10/30/2025 at 21:05, 1 month 5 days ago Rapport semestriel et restructuration financière de TME Pharma Résultats Financiers Biotechnologie Emission D'obligations Nomination Du PDG TME Pharma
BRIEF published on 10/30/2025 at 21:05, 1 month 5 days ago TME Pharma's Semi-Annual Report and Financial Restructuring Financial Results Biotechnology CEO Appointment Bond Issuance TME Pharma
PRESS RELEASE published on 10/30/2025 at 21:00, 1 month 5 days ago TME Pharma publishes its semi annual results and half-year report TME Pharma publishes semi annual results and half-year report showing cost reductions, new CEO, and fundraising activities. Focus on NOX-A12 and NOX-E36 assets Fundraising Cost Reductions TME Pharma NOX-A12 Semi Annual Results
PRESS RELEASE published on 09/01/2025 at 08:45, 3 months 4 days ago Inside Information: Other news releases TME Pharma completes August financing, with €500k cash received on August 28th, bringing cash position to €2.35M. Organization aims to attract financing for cancer and eye therapies Cash Position TME Pharma August Financing Cost-efficient Organization Novel Therapies
BRIEF published on 09/01/2025 at 08:45, 3 months 4 days ago TME Pharma successfully completes its August fundraising round Biotechnology Fundraising Treasury Cryptocurrencies Cancer
BRIEF published on 09/01/2025 at 08:45, 3 months 4 days ago TME Pharma conclut avec succès sa levée de fonds d'août Biotechnologie Trésorerie Levée De Fonds Cryptomonnaies Cancer
PRESS RELEASE published on 09/01/2025 at 08:40, 3 months 4 days ago Informations privilégiées:Autres communiqués TME Pharma finalise une levée de fonds de 500 k € en espèces en août, atteignant une trésorerie de 2,35 M € pour développer de nouvelles thérapies contre le cancer et les maladies oculaires Trésorerie Levée De Fonds Cancer TME Pharma Thérapies
BRIEF published on 08/25/2025 at 08:05, 3 months 11 days ago TME Pharma obtient 500 000 € grâce à une nouvelle émission obligataire Stratégie Financière Stratégie D'investissement Emission D'obligations Réduction Des Coûts Engagements Des Actionnaires
BRIEF published on 08/25/2025 at 08:05, 3 months 11 days ago TME Pharma Secures €500,000 through New Bond Issue Investment Strategy Cost Reduction Bond Issuance Financial Strategy Shareholder Commitments
PRESS RELEASE published on 08/25/2025 at 08:00, 3 months 11 days ago Inside Information / Other news releases TME Pharma to raise €500k through bond issue & receives new shareholding notice. CEO & Chairman also invest. Funds to boost financial position & support R&D projects & investment strategy Fundraising Shareholding CEO Bond Issue TME Pharma
Published on 12/05/2025 at 02:35, 6 hours 44 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 19 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 14 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 19 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:05, 13 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 34 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 34 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 36 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 4 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 19 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
